Overall, we have developed an iPSC-based human spinal MN disease model of UBQLN2-ALS, showing the acquisition of the hallmark pathology—including motor neuron death and protein aggregation—during cellular aging or oxidative stress treatment. Here, UBQLN2 is linked to amyotrophic lateral sclerosis.